192 related articles for article (PubMed ID: 33411315)
21. Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model.
Salehi P; Akinpelu OV; Waissbluth S; Peleva E; Meehan B; Rak J; Daniel SJ
Otol Neurotol; 2014 Aug; 35(7):1131-9. PubMed ID: 24841915
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
[TBL] [Abstract][Full Text] [Related]
23. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
24. Assessment of cochlear toxicity in response to chronic 3,3'-iminodipropionitrile in mice reveals early and reversible functional loss that precedes overt histopathology.
Greguske EA; Llorens J; Pyott SJ
Arch Toxicol; 2021 Mar; 95(3):1003-1021. PubMed ID: 33495873
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal Negative Regulation Between Lmx1a and Lmo4 Is Required for Inner Ear Formation.
Huang Y; Hill J; Yatteau A; Wong L; Jiang T; Petrovic J; Gan L; Dong L; Wu DK
J Neurosci; 2018 Jun; 38(23):5429-5440. PubMed ID: 29769265
[TBL] [Abstract][Full Text] [Related]
26. Quantitative profiling of cochlear synaptosomal proteins in cisplatin-induced synaptic dysfunction.
Shahab M; Rosati R; Stemmer PM; Dombkowski A; Jamesdaniel S
Hear Res; 2024 Jun; 447():109022. PubMed ID: 38705005
[TBL] [Abstract][Full Text] [Related]
27. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin ototoxicity involves cytokines and STAT6 signaling network.
Kim HJ; Oh GS; Lee JH; Lyu AR; Ji HM; Lee SH; Song J; Park SJ; You YO; Sul JD; Park C; Chung SY; Moon SK; Lim DJ; So HS; Park R
Cell Res; 2011 Jun; 21(6):944-56. PubMed ID: 21321603
[TBL] [Abstract][Full Text] [Related]
29. Pannexin 1 deficiency can induce hearing loss.
Zhao HB; Zhu Y; Liang C; Chen J
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):143-7. PubMed ID: 26002464
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice.
Liu Z; Zhang H; Hong G; Bi X; Hu J; Zhang T; An Y; Guo N; Dong F; Xiao Y; Li W; Zhao X; Chu B; Guo S; Zhang X; Chai R; Fu X
Mol Ther; 2024 May; 32(5):1387-1406. PubMed ID: 38414247
[TBL] [Abstract][Full Text] [Related]
32. ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring.
Dille MF; Ellingson RM; McMillan GP; Konrad-Martin D
J Am Acad Audiol; 2013 Oct; 24(9):769-81. PubMed ID: 24224985
[TBL] [Abstract][Full Text] [Related]
33. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
34. Endoplasmic Reticulum Stress Is Involved in Cochlear Cell Apoptosis in a Cisplatin-Induced Ototoxicity Rat Model.
Zong S; Liu T; Wan F; Chen P; Luo P; Xiao H
Audiol Neurootol; 2017; 22(3):160-168. PubMed ID: 29049998
[TBL] [Abstract][Full Text] [Related]
35. Otoprotective Effects of Zingerone on Cisplatin-Induced Ototoxicity.
Lee CH; Lee DH; Lee SM; Kim ASY
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429117
[TBL] [Abstract][Full Text] [Related]
36. LIM domain only 4 (LMO4) regulates calcium-induced calcium release and synaptic plasticity in the hippocampus.
Qin Z; Zhou X; Gomez-Smith M; Pandey NR; Lee KF; Lagace DC; Béïque JC; Chen HH
J Neurosci; 2012 Mar; 32(12):4271-83. PubMed ID: 22442089
[TBL] [Abstract][Full Text] [Related]
37. Apelin-13 protects against cisplatin-induced ototoxicity by inhibiting apoptosis and regulating STAT1 and STAT3.
Yin H; Sun Y; Ya B; Guo Y; Zhao H; Zhang L; Wang F; Zhang W; Yang Q
Arch Toxicol; 2023 Sep; 97(9):2477-2493. PubMed ID: 37395757
[TBL] [Abstract][Full Text] [Related]
38. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
39. Autophagy-dependent ferroptosis contributes to cisplatin-induced hearing loss.
Jian B; Pang J; Xiong H; Zhang W; Zhan T; Su Z; Lin H; Zhang H; He W; Zheng Y
Toxicol Lett; 2021 Oct; 350():249-260. PubMed ID: 34302894
[TBL] [Abstract][Full Text] [Related]
40. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition.
Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG
Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
